CNSP
Price
$8.40
Change
-$0.08 (-0.94%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
4.87M
PMN
Price
$0.41
Change
-$0.02 (-4.65%)
Updated
Sep 23, 04:59 PM (EDT)
Capitalization
22.22M
50 days until earnings call
Interact to see
Advertisement

CNSP vs PMN

Header iconCNSP vs PMN Comparison
Open Charts CNSP vs PMNBanner chart's image
CNS Pharmaceuticals
Price$8.40
Change-$0.08 (-0.94%)
Volume$100
Capitalization4.87M
ProMIS Neurosciences
Price$0.41
Change-$0.02 (-4.65%)
Volume$300
Capitalization22.22M
CNSP vs PMN Comparison Chart in %
Loading...
CNSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CNSP vs. PMN commentary
Sep 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNSP is a Hold and PMN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 24, 2025
Stock price -- (CNSP: $8.48 vs. PMN: $0.43)
Brand notoriety: CNSP and PMN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNSP: 28% vs. PMN: 6%
Market capitalization -- CNSP: $4.87M vs. PMN: $22.22M
CNSP [@Biotechnology] is valued at $4.87M. PMN’s [@Biotechnology] market capitalization is $22.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.23B to $0. The average market capitalization across the [@Biotechnology] industry is $1.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNSP’s FA Score shows that 2 FA rating(s) are green whilePMN’s FA Score has 0 green FA rating(s).

  • CNSP’s FA Score: 2 green, 3 red.
  • PMN’s FA Score: 0 green, 5 red.
According to our system of comparison, CNSP is a better buy in the long-term than PMN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNSP’s TA Score shows that 6 TA indicator(s) are bullish while PMN’s TA Score has 4 bullish TA indicator(s).

  • CNSP’s TA Score: 6 bullish, 4 bearish.
  • PMN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CNSP is a better buy in the short-term than PMN.

Price Growth

CNSP (@Biotechnology) experienced а -7.83% price change this week, while PMN (@Biotechnology) price change was +2.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.94%. For the same industry, the average monthly price growth was +8.31%, and the average quarterly price growth was +48.45%.

Reported Earning Dates

PMN is expected to report earnings on Nov 12, 2025.

Industries' Descriptions

@Biotechnology (+2.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PMN($22.2M) has a higher market cap than CNSP($4.87M). PMN has higher P/E ratio than CNSP: PMN (7.78) vs CNSP (0.00). PMN YTD gains are higher at: -54.737 vs. CNSP (-88.261). PMN has higher annual earnings (EBITDA): -8.43M vs. CNSP (-15.44M). CNSP has more cash in the bank: 12.1M vs. PMN (4.54M). CNSP has less debt than PMN: CNSP (122K) vs PMN (4.05M). CNSP (0) and PMN (0) have equivalent revenues.
CNSPPMNCNSP / PMN
Capitalization4.87M22.2M22%
EBITDA-15.44M-8.43M183%
Gain YTD-88.261-54.737161%
P/E Ratio0.007.780%
Revenue00-
Total Cash12.1M4.54M266%
Total Debt122K4.05M3%
FUNDAMENTALS RATINGS
CNSP vs PMN: Fundamental Ratings
CNSP
PMN
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
94
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
6591
P/E GROWTH RATING
1..100
798
SEASONALITY SCORE
1..100
650

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CNSP's Valuation (9) in the null industry is significantly better than the same rating for PMN (94). This means that CNSP’s stock grew significantly faster than PMN’s over the last 12 months.

CNSP's Profit vs Risk Rating (100) in the null industry is in the same range as PMN (100). This means that CNSP’s stock grew similarly to PMN’s over the last 12 months.

PMN's SMR Rating (96) in the null industry is in the same range as CNSP (100). This means that PMN’s stock grew similarly to CNSP’s over the last 12 months.

CNSP's Price Growth Rating (65) in the null industry is in the same range as PMN (91). This means that CNSP’s stock grew similarly to PMN’s over the last 12 months.

CNSP's P/E Growth Rating (7) in the null industry is significantly better than the same rating for PMN (98). This means that CNSP’s stock grew significantly faster than PMN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CNSPPMN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
84%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
CNSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PMN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UTMD63.271.08
+1.74%
Utah Medical Products
ESQ104.240.83
+0.80%
Esquire Financial Holdings
EA173.420.33
+0.19%
Electronic Arts
FELE95.480.15
+0.16%
Franklin Electric Co
NCRA1.49-0.04
-2.61%
Nocera

CNSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CNSP has been loosely correlated with PMN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if CNSP jumps, then PMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNSP
1D Price
Change %
CNSP100%
+6.27%
PMN - CNSP
51%
Loosely correlated
-2.83%
BRCTF - CNSP
37%
Loosely correlated
+8.48%
MURA - CNSP
31%
Poorly correlated
-0.48%
CRMD - CNSP
27%
Poorly correlated
+0.63%
GLTO - CNSP
27%
Poorly correlated
+4.53%
More

PMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, PMN has been loosely correlated with CNSP. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PMN jumps, then CNSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PMN
1D Price
Change %
PMN100%
-2.83%
CNSP - PMN
51%
Loosely correlated
+6.27%
NEVPF - PMN
49%
Loosely correlated
N/A
BBIO - PMN
40%
Loosely correlated
-1.58%
ABOS - PMN
29%
Poorly correlated
+1.59%
LITS - PMN
26%
Poorly correlated
-7.86%
More